RT Journal Article
SR Electronic
T1 Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003697
DO 10.1136/jitc-2021-003697
VO 10
IS 1
A1 Zucali, Paolo Andrea
A1 Lin, Chia-Chi
A1 Carthon, Bradley C
A1 Bauer, Todd M
A1 Tucci, Marcello
A1 Italiano, Antoine
A1 Iacovelli, Roberto
A1 Su, Wu-Chou
A1 Massard, Christophe
A1 Saleh, Mansoor
A1 Daniele, Gennaro
A1 Greystoke, Alastair
A1 Gutierrez, Martin
A1 Pant, Shubham
A1 Shen, Ying-Chun
A1 Perrino, Matteo
A1 Meng, Robin
A1 Abbadessa, Giovanni
A1 Lee, Helen
A1 Dong, Yingwen
A1 Chiron, Marielle
A1 Wang, Rui
A1 Loumagne, Laure
A1 Lépine, Lucie
A1 de Bono, Johann
YR 2022
UL http://jitc.bmj.com/content/10/1/e003697.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.